Information was received from a patient with an implanted neurostimulator (ins) for urinary dysfunction/sacral nerve stim and gastrointestinal/pelvic floor therapy.It was reported that they were having leakage more than anything else at night and that they couldn't even feel that they were leaking, so they turned the stimulation up and it got better but then the stimulation started to get uncomfortable and it seemed to be affecting their back/they were feeling it in their back.The patient stated they turned the stimulation back down but it was still hurting.The patient stated that this first started happening over a couple of weeks ago now.The patient stated they had just moved so they did not have a managing health care provider (hcp) at this time.Patient services sent the patient physician listings at the patient's request and reviewed programming and stimulation considerations with the patient.The patient stated the last time they'd been switched to a new program had been at their previous health care provider (hcp) office so they stated they would research a new hcp and in the meantime try switching to a different program and monitoring their symptoms.Patient also stated that the charging cable for their j3 and communicator was frayed.Patient services asked the patient when they noticed the issue but the patient did not answer that question, they just stated they were borrowing their daughter's charging cable in the meantime to charge their external devices and requested a new charging cable.Patient services emailed the repair team to send the patient a new charging cable.Patient services warm transferred the patient to device registration at call's end to update their address.Documented reported event.No further action was taken by patient services.
|
B3: date is approximate.Year is confirmed valid.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|